News | June 15, 2010

New Ablation Catheter Measures Contact Force

June 15, 2010 – The first ablation catheter that indicates the contact force of the catheter against the wall of the heart was recently released in Europe. Biotronik partnered with Endosense for the creation of the TactiCath catheter.

The irrigated radio frequency (RF) contact force ablation catheter offers an advance in ablation therapy for patients with cardiac arrhythmias, particularly atrial fibrillation (AF).

“The ability to sense contact force will shift the paradigm of how electrophysiologists plan and execute ablation therapies; the potential for improved patient outcomes is very exciting,” said professor Richard Schilling at St. Bartholomew’s Hospital, London.

A major challenge that physicians face when they treat patients with AF is manipulating the ablation catheter in the highly variable anatomy of the left heart with precisely the right amount of pressure to effectively ablate cardiac tissue without causing damage. The new TactiCath is the first commercially available irrigated force sensing RF ablation catheter that can provide physicians with objective measures of contact force, reliably and in real-time. This technology should improve the efficacy, safety and reproducibility of catheter ablation procedures.

For more information: www.biotronik.com


Related Content

News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
Subscribe Now